SLC5A2 and diabetes mellitus: For example, the association of diabetes mellitus with kidney failure may be reduced with the introduction of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and the predictive value of diabetes mellitus for kidney failure may subsequently decrease.